Approval · Notice of Compliance 8392 · 2006
SATIVEX: Notice of Compliance 8392
Issued November 7, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
Issued with conditions (NOC/c): the company must confirm the benefit in further studies.
- Notice number
- 8392
- Date
- November 7, 2006
- Company
- Gw Pharma Limited
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the product monograph
- Therapeutic class
- Cannabinoid analgesic
- With conditions
- Yes (NOC/c)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SATIVEX | Not yet assigned | — |
Medicinal ingredients
- DELTA-9-TETRAHYDROCANNABINOL 27 MG per ML
- CANNABIDIOL 25 MG per ML